IMCI-PLUS is an inter-disciplinary, Pan-African-EU research partnership, with emphasis on capacity strengthening and mutual learning, to improve management of pediatric lower respiratory tract infections (LRTI)–the leading cause of child morbidity and mortality in Sub-Saharan Africa (SSA)–by working…

The WHO Department of Maternal, Newborn, Child and Adolescent Health and Ageing (WHO/MCA) will coordinate a multi-country, multi-centre randomised controlled trial to evaluate the effect of approaches to prevent and manage growth faltering in the first six months of life on wasting-free survival at…

The European Consortium "Antiviral Therapeutics for Rapid Response Against Pandemic Infectious Diseases" (AVITHRAPID) aims to support the search for novel broad-spectrum antiviral compounds by advancing multiple approaches. Building on a pre-existing set of bioactive small molecules, which are at…

 The aim of this translational research project is to conduct a first in human (clinical phase I) study and test BAP5191, a new formulation intended to be a cure for cutaneous leishmaniasis – a neglected stigmatizing and debilitating tropical disease with an estimated 600 000 to 1 million of new…